Abstract
The use of calcineurin inhibitors (CNI) is associated with significant nephrotoxicity, especially DGF in recipients of marginal allografts. Acute nephrotoxicity, which occurs in the early period after transplantation, leads to a higher rate of dialysis, and chronic nephrotoxicity may eventually result in graft loss. Avoidance of CNI for a prolonged period de novo after cadaver donor (CD) renal transplantation may facilitate recovery from DGF. Sirolimus (SRL) and mycophenolate mofetil (MMF) can be administered in the setting of DGF without exacerbating the impaired renal function after transplantation. To study the efficacy and tolerability of using a CNI-free induction protocol, a SRL-MMF combination plus interleukin-2R: (IL2R) antibody (basiliximab-Simulect) induction was administered to 24 consecutive adult recipients of marginal CD transplants (ie, donor age over 60 years, history of longstanding hypertension or diabetes mellitus, or cold ischemia time over 36 hours).
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
